Neuromuscular symptoms and elevated creatine kinase after statin withdrawal

New England Journal of Medicine

Volumn 362, Issue 6, 2010, Pages 564-565

  Echaniz Laguna, Andoni ^a   Mohr, Michel ^a   Tranchant, Christine ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE DURATION; ELECTROMYOGRAM; FEMALE; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; KENNEDY DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE NECROSIS; MUSCLE TOXICITY; MUSCLE WEAKNESS; MYALGIA; NEUROMUSCULAR DISEASE; PARANEOPLASTIC SYNDROME; POLYMYOSITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOLYSIS; SEX DIFFERENCE; SIDE EFFECT; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 76649134128     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0908215     Document Type: Letter

References (5)

1. Sirvent P, Mercier J, Lacampagne A. New insights into mechanisms of statin-associated myotoxicity. Curr Opin Pharmacol 2008;8:333-8.
2. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003;289:1681-90.
3. Tsivgoulis G, Spengos K, Karandreas N, Panas M, Kladi A, Manta P. Presymptomatic neuromuscular disorders disclosed following statin treatment. Arch Intern Med 2006;166:1519-24.
4. Thompson PD, Clarkson PM, Rosenson AS. An assessment of statin safety by muscle experts. Am J Cardiol 2006;97:Suppl 1: S69-S76.
5. Hilton-Jones D. Myopathy associated with statin therapy. Neuromuscul Disord 2008;18:97-8.